Article
Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease.
Neurochemistry international - 1 Oct 2012
van Tijn Paula, Dennissen Frank J A, Gentier Romina J G, Hobo Barbara, Hermes Denise, Steinbusch Harry W M, Van Leeuwen Fred W, Fischer David F
Abstract excerpt
The mutant ubiquitin UBB(+1) is a substrate as well as an inhibitor of the ubiquitin-proteasome system (UPS) and accumulates in the neuropathological hallmarks of Alzheimer's disease (AD). A role for the UPS has been suggested in the generation of amyloid β (Aβ) plaques in AD. To investigate the effect of UBB(+1) expression on amyloid pathology in vivo, we crossed UBB(+1) transgenic mice with a transgenic line...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
